EMA updates three drug registration guides with new information on orphans
This article was originally published in SRA
Executive Summary
The European Medicines Agency has added information on orphan medicinal products to three of its guidelines dealing with pre- and post-authorization procedures, and on marketing authorization of generic/hybrid medicinal products1-4.